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Floxed-Cassette Allelic Exchange Mutagenesis Enables
Markerless Gene Deletion in Chlamydia trachomatis and Can
Reverse Cassette-Induced Polar Effects
G. Keb,a R. Hayman,a K. A. Fieldsa
aDepartment of Microbiology, Immunology & Molecular Genetics, University of Kentucky College of Medicine,
Lexington, Kentucky, USA
ABSTRACT As obligate intracellular bacteria, Chlamydia spp. have evolved numer-
ous, likely intricate, mechanisms to create and maintain a privileged intracellular
niche. Recent progress in elucidating and characterizing these processes has been
bolstered by the development of techniques enabling basic genetic tractability.
Florescence-reported allelic exchange mutagenesis (FRAEM) couples chromosomal
gene deletion with the insertion of a selection cassette encoding antibiotic resis-
tance and green fluorescent protein (GFP). Similar to other bacteria, many chlamyd-
ial genes exist within polycistronic operons, raising the possibility of polar effects
mediated by insertion cassettes. Indeed, FRAEM-mediated deletion of Chlamydia tra-
chomatis tmeA negatively impacts the expression of tmeB. We have adapted FRAEM
technology by employing a gfp-bla cassette flanked by loxP sites. Conditional ex-
pression of Cre recombinase in Chlamydia tmeA containing a floxed cassette resulted
in deletion of the marker and restoration of tmeB expression.
IMPORTANCE C. trachomatis infections represent a significant burden to human
health. The ability to genetically manipulate Chlamydia spp. is overcoming historic
confounding barriers that have impeded rapid progress in understanding overall
chlamydial pathogenesis. The current state of genetic manipulation in Chlamydia
spp. requires further development, including mechanisms to generate markerless
gene disruption. We leveraged a stepwise Cre-lox approach to excise selection
marker genes from a deleted gene locus. We found this process to be efficient, and
the removal of extraneous elements resulted in the reversal of a negative polar ef-
fect on a downstream gene. This technique facilitates a more direct assessment of
gene function and adds to the Chlamydia molecular toolbox by facilitating the dele-
tion of genes within operons.
KEYWORDS TmeA, type III secretion, FRAEM, mutagenesis, Chlamydia
The obligate intracellular bacterium Chlamydia trachomatis represents a significantburden to human health worldwide. Ocular infections with serovars A to C can lead
to blinding trachoma, whereas genital infections mediated by serovars D to K or LGV1
to LGV3 result in typical sexually transmitted disease or lymphogranuloma venereum,
respectively (1). Chlamydia spp. manifest a biphasic developmental cycle where infec-
tious elementary bodies (EBs) and vegetative reticulate bodies (RBs) represent distinct
developmental forms (2). Development occurs entirely within a parasitophorous vesicle
termed an inclusion. Beginning as early as attachment and invasion, chlamydiae
orchestrate changes in host cell biology to create and maintain a productive growth
environment. Major affected pathways include the host cytoskeleton, membrane and
vesicle trafficking, host cell survival, and immune signaling (3).
Like other Gram-negative pathogens (4), Chlamydia spp. express a type III secretion
system (T3SS) that secretes and translocates effector proteins (T3SE) whose antihost
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activities culminate to create and maintain a hospitable intracellular niche (3). T3S
activity occurs as early as invasion (5, 6) and likely continues until RBs differentiate back
into EBs. Effectors that intercalate into the inclusion membrane (Incs) were first iden-
tified bioinformatically by the presence of a ca. 60-residue predicted hydrophobic
domain (7) and represent the most thoroughly characterized group of chlamydial
T3SEs. Surrogate T3SSs and protein localization studies have previously been leveraged
to identify an additional pool of chlamydial effectors that are translocated beyond the
inclusion membrane and target host proteins within the cytoplasm or organelles (3).
The total number of T3S substrates likely exceeds 60 effectors (8), yet the functional role
for the majority of these proteins remains to be elucidated.
Due to genetic intractability, it was historically difficult to provide definitive evi-
dence regarding how chlamydial gene products contribute to development and patho-
genesis; however, the acquisition of tools to genetically manipulate chlamydiae now
provides opportunities to more efficiently reveal aspects of infection biology (reviewed
in references 9 to 11). Early advances relied on elegant chemical mutagenesis strategies
applied in forward and reverse genetic approaches to associate genes with particular
phenotypes. The ability to coinfect chlamydial strains to exchange DNA via lateral gene
transfer (LGT) was exploited for gene association studies in heavily mutagenized
genomes (12). CaCl2 chemical transformation of C. trachomatis (13) with exogenous
plasmid DNA has led to the development of more targeted strategies, including use of
the TargeTron system (14) and fluorescence-reported allelic exchange mutagenesis
(FRAEM) (15). The TargeTron system enables site-specific gene inactivation by insertion
of a group II intron, whereas complete coding sequences are deleted by FRAEM and
replaced with a marker cassette encoding green fluorescent protein (GFP) and BlaM.
Ectopic expression of epitope-tagged gene products has also been employed to study
effector localization and function (16–18). Most recently, the expression of enzymati-
cally dead Cas9 was leveraged for conditional knockdown of targeted messages (19).
Organization of genes into polycistronic operons is a common strategy for coordi-
nated gene expression in bacteria. For example, high-resolution RNA sequencing
(RNA-seq) analyses have indicated over 1,500 operons in Escherichia coli K-12 (20).
Consistent with a reductionist genome, many genes in C. trachomatis are likely also
arranged in operons. Indeed, genes encoding the basal T3S apparatus are arranged
within 10 different operons (21). T3SE-specific genes are distributed throughout the
genome, and several of the Inc proteins are clearly encoded within operons (22). In
addition, the translocated membrane-associated effectors A and B (TmeA and TmeB,
respectively) are cotranscribed. The two effectors share the same T3S chaperone (23)
and are secreted during invasion (24, 25). FRAEM-mediated mutagenesis revealed an
active requirement for TmeA in invasion of cultured cells and in intravaginal infection
of mice (26). Importantly, the tmeA strain also failed to express tmeB. Although the
invasion phenotype could be complemented by transexpression of tmeA, the loss of
tmeB complicates the interpretation of functional study results.
The FRAEM and TargeTron techniques require the insertion of fluorescence reporter
and/or antibiotic resistance genes to detect and/or select for successful gene disrup-
tion. These insertions have the potential to alter the expression of cotranscribed genes.
It would therefore be advantageous to have a mechanism of creating markerless gene
deletions to avoid the possibility of polar effects. Bacteriophage Cre recombinase has
been used effectively for genome editing of DNA flanked by engineered loxP recog-
nition sequences (27). In particular, the Cre-lox system has been applied successfully in
genetically tractable bacteria (28), including the intracellular pathogen Coxiella burnetii
(29). Although the obligate intracellular nature and comparatively limited malleability
of Chlamydia spp. present challenges, the broadly efficacious Cre-lox approach repre-
sents an attractive possibility for genome editing in Chlamydia species.
The goal of the work presented herein was to develop an approach for markerless
gene deletion using floxed insertion cassettes and transiently expressed Cre recombi-
nase. We focused on tmeA to test whether removal of the reporter cassette from a tmeA
deletion strain would restore the expression of TmeB. A floxed-cassette tmeA mutant
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was generated via FRAEM, and transient production of Cre was accomplished by
expression with the suicide plasmid pSUmC. The expression of Cre resulted in excision
of the gfp-bla cassette, and cultivation under nonselective conditions resulted in curing
of the suicide plasmid and cre. Importantly, the new tmeA mutant expressed TmeB, and
the new tmeA mutant retained the previously observed invasion phenotype. Hence, the
application of Cre-lox genome editing in C. trachomatis can be utilized in combination
with FRAEM for markerless gene deletion. This approach provides the field with a novel
technique for genetic manipulation of C. trachomatis.
RESULTS
Excision strategy and cre activity. We hypothesized that the lack of TmeB in C.
trachomatis L2 tmeA was due directly to the replacement of tmeA with the 2.1-kb
gfp-bla selection marker. We chose to employ Cre-lox genome editing to investigate
whether removal of the cassette could restore tmeB expression in the tmeA mutant
strain. This strategy requires a mutant strain created using a suicide plasmid where a
gfp-bla selection cassette, flanked by 34-bp loxP sites, replaces the target gene. The
strain is then transformed with a Cre-encoding plasmid. Expression is maintained until
excision of the chromosomal cassette is accomplished, yielding a single loxP scar
sequence in place of the targeted gene (Fig. 1A). Transient production of Cre in
Chlamydia spp. was accomplished by expression of cre on the suicide plasmid pSUmC.
In addition to constitutively expressed Cre, pSU-CRE expresses AadA and mCherry for
selection and detection, respectively (Fig. 1B). E. coli was used to test the functional
integrity of Cre and to confirm the overall efficiency of the system. E. coli was
cotransformed with pSU-CRE and ploxP-GFP expressing blaM on the plasmid backbone
and a floxed cassette containing gfp. Cotransformation with pSUmC was used as a
negative control. We examined 100 plated colonies by direct fluorescence 24 h after
transformation. No green bacteria were observed in the presence of pSU-CRE, whereas
all colonies were both red and green in the presence of empty pSUmC (Fig. 1C). To
FIG 1 Cre recombinase excises a fluorescence cassette in E. coli. (A) Schematic representation of Cre recombinase strategy
for use in Chlamydia spp. Cre expression is used to excise the GFP and -lactamase resistance (Res) reporter genes when
flanked by upstream (US) and downstream (DS) loxP sites, leaving behind a loxP scar sequence. The resulting locus is shown
and contains one remaining loxP site. (B) Schematic of pSU-CRE plasmid for conditional expression of Cre in C. trachomatis.
(C) E. coli colonies expressing ploxP-GFP and lacking (pSUmC) or expressing (pSU-CRE) Cre recombinase. Colonies were
imaged with bright-field and fluorescence microscopy. (D) Excision of the reporter cassette was confirmed for three
different transformants (1 to 3) by PCR amplification of the locus with primers annealing within the upstream and
downstream flanking regions.
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confirm excision of the cassette from ploxP-GFP, plasmid DNA was harvested from
multiple E. coli isolates, and the cassette locus was PCR amplified using primers
annealing to regions flanking the loxP sites. All amplicons from the pSU-CRE-
transformed E. coli strains migrated at a size smaller than the pSUmC control, corre-
sponding to loss of the gfp-containing DNA (Fig. 1D). These data indicated that the
pSU-CRE-encoded recombinase was functional and that excision was efficient in E. coli.
We next investigated the expression of Cre by chlamydiae. C. trachomatis L2 was
transformed with pSU-CRE, and protein samples were harvested from monolayers
infected with either wild-type (WT) or C. trachomatis/pSU-CRE for 24 h. Cre was de-
tected via immunoblotting only in the presence of pSU-CRE (Fig. 2A). Although the
inclusions formed by pSU-CRE-expressing chlamydiae appeared to be normal (not
shown), we wanted to confirm that the expression of Cre had no obvious negative
impact on chlamydial fitness. Chlamydia spp. expressing or lacking Cre were used to
infect HeLa cells for 24 h. Cultures were then either methanol fixed and stained for
inclusion area analysis or disrupted for enumeration of progeny inclusion-forming units
(IFU). As expected, there was no significant difference in inclusion areas or production
of progeny IFUs. Therefore, Cre is stably expressed in Chlamydia spp. and does not
overtly impact chlamydial development.
Generation of a markerless tmeA mutant. Our approach to create a markerless
tmeA strain began by creating a new tmeA mutant. WT C. trachomatis L2 was trans-
formed with pSUmC-tmeA-lox-gfp-bla, and FRAEM was performed as previously de-
scribed (15, 30). Isolates were then subjected to cultivation in the presence of rifampin
(Rif) to select Rif-resistant chlamydiae, and a clonal strain was derived by limiting
dilution. The resulting strain, L2Rif tmeA-lx-gfp-bla, contained a floxed gfp-bla cassette in
place of tmeA and served as the progenitor for genomic editing (Fig. 3A). We were
unable to transform this strain with pSU-CRE after several attempts. We therefore
leveraged lateral gene transfer (LGT) to mobilize pSU-CRE from WT L2 by coinfection
with L2Rif tmeA-lx-gfp-bla and selecting for red and green inclusions that were resistant
to Rif, penicillin G (PenG), and spectinomycin (Spec). Cultures were maintained in the
presence of anhydrotetracycline (aTc) to promote the retention of pSU-CRE. Red-only
inclusions were observed after one passage in the absence of PenG, indicating suc-
cessful excision of the gfp-bla cassette. Because this process yielded a mixed population
of chlamydiae (lacking or still containing the gfp-bla cassette), Rif- and Spec-resistant
red-only Chlamydia spp. were clonally isolated by limiting dilution. Curing of pSU-CRE
was then achieved by multiple passages in the absence of Spec and aTc. Phenotypic
and PCR analyses indicated that the resulting strain, L2RRif tmeA-lx, had also been cured
of the endogenous plasmid pL2 (not shown). We therefore performed coinfections with
WT L2 and L2RRif tmeA-lx to restore pL2 via LGT to yield L2Rif tmeA-lx.
FIG 2 Cre is expressed in Chlamydia spp. and does not impact development. HeLa cells were infected for 24 h with equivalent IFUs
of C. trachomatis expressing (CRE) or lacking (-CRE) pSU-CRE. (A) Whole-culture material was probed in immunoblots with
Cre-specific antibodies or anti-Hsp60 as the loading control and visualized via chemiluminescence. (B) Cultures were methanol fixed
and stained for inclusion visualization using indirect immunofluorescence. Areas of 50 representative inclusions were measured and
plotted individually, with the means and standard deviations shown. (C) Primary cultures were harvested, and progeny Chlamydia spp.
were enumerated after secondary passage onto fresh HeLa cells.
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Sensitivity to PenG was assayed as an indicator for loss of the gfp-bla cassette (Fig.
3B). Genomes of Chlamydia spp. grown in antibiotic-supplemented media were enu-
merated over three passages. In contrast to L2 tmeA retaining gfp-bla, WT and tmeA-lx
mutant Chlamydia sp. levels dropped below detection by the third passage with PenG.
Finally, we confirmed the presence of pL2 via quantitative PCR (qPCR) (Fig. 3C). Levels
of pL2 in the tmeA-lx mutant were comparable to the WT, indicating restoration of the
endogenous plasmid. Overall, our strategy resulted in the generation of a markerless
tmeA deletion strain.
We next focused directly on the tmeA locus to verify that genome editing occurred
in accordance with our design. Analysis of genomic DNA via qPCR from the WT, tmeA
mutant, or tmeA-lx mutant Chlamydia strains confirmed the absence of tmeA and
retention of tmeB (Fig. 4A). In addition, a gfp-specific signal was detected for only the
tmeA mutant, and no cre-specific signal was detected for any strain. These data
confirmed the complete loss of both the gfp-bla cassette and cre in the tmeA-lx mutant.
Excision of the gfp-bla cassette should reduce the locus by ca. 2.1 kb. This was tested
by PCR using primers flanking the locus (Fig. 4B). The amplicons from WT and tmeA
mutant Chlamydia strains migrated at the expected 1.4 and 2.9 kb, respectively. The
tmeA-lx amplicon migrated at ca. 0.5 kb, corresponding to the loss gfp-bla. Finally, we
directly sequenced the locus (Fig. 4C). As expected, a single loxP site was detected
positioned immediately after the tmeA initiation codon and prior to the stop codon. The
intervening sequence leading up to tmeB and the GTG start were not altered from those
of the WT. In aggregate, our data indicate the successful generation of a markerless
tmeA mutant using Cre-lox.
Excision of the gfp-bla cassette reverses polar disruption of tmeB expression.
Having established a successful removal of a floxed gfp-bla cassette to yield L2Rif
tmeA-lx, we tested whether or not the goal of alleviating polar effects on tmeB was
achieved. RNA and protein analyses were conducted on material extracted from 24-h
cultures to examine tmeB-specific products (Fig. 5). When signals were normalized for
rpoD levels, approximately similar levels of tmeA- and tmeB-specific amplicons were
detected in the WT. As expected, no signal was detected for tmeA and tmeB in the
FIG 3 Construction of a markerless Chlamydia tmeA mutant. (A) Schematic representation of the strategy used to create a markerless
tmeA mutant. Each intermediate is depicted with fluorescent qualities (green, GFP; red, mCherry; gray, no fluorescence) and
antibiotic sensitivities. (B) McCoy cell cultures were infected with equal IFUs of WT, L2 tmeA, or L2Rif tmeA-lx C. trachomatis and serially
passaged every 24 h in medium containing PenG. At each passage, DNA was harvested for quantitative real-time PCR to determine
genome equivalents based on chlamydial 16S rRNA. (C) qPCR-based comparison of endogenous pL2 (plasmid) copy number in WT
or tmeA-lx mutant chlamydiae relative to chlamydial 16S rRNA. DNA was harvested from infected McCoy cells at 24 hpi. PenGr,
penicillin G resistant; PenGs, penicillin susceptible; Rifr, rifampin resistant; Specs, spectinomycin susceptible; Specr, spectinomycin
resistant.
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respective null backgrounds. Levels of tmeB appeared to be reduced in the polar tmeA
mutant containing a gfp-bla cassette. However, tmeB was restored to WT levels in the
tmeA-lx mutant. Previous work has indicated that ct696 is transcribed independently of
tmeA and tmeB (25), and no changes in ct696 message were observed among the tested
strains. Western blot data for TmeA and TmeB were consistent with reverse transcription-
quantitative PCR (qRT-PCR) results (Fig. 5B). TmeB was absent in lysates from tmeA Chla-
mydia spp. but was restored in the tmeA-lx mutant. Hence, the remaining loxP scar
sequence did not affect TmeB expression. Interestingly, TmeB appeared to be more
abundant in the tmeA-lx mutant complemented in trans with tmeA.
We have previously shown that the elimination of tmeA manifests as a defect in
invasion efficiency that correlates with a reduction in inclusion numbers in primary and
secondary cultures (26). Since this strain also lacked TmeB, we could not formally
exclude the possibility that the loss of this effector contributed to the observed
phenotypes. To ensure valid phenotypic comparisons, we generated a Rif-resistant WT
strain expressing pCompAII. Likewise, a tmeA-lx vector-only mutant was used as an
isogenic control for the complementation tmeA-lx ptmeA mutant. HeLa cell cultures
were infected with chlamydial strains normalized for particles (Fig. 6, left) or IFUs (Fig.
6, right). Inclusions were enumerated in particle-normalized cultures at 24 h postinfec-
tion, whereas IFU-normalized cultures were harvested and passaged onto fresh cells for
enumeration of progeny EBs. In both cases, infection was significantly reduced for the
tmeA-lx mutant compared to the WT. This deficiency could be reversed by comple-
mentation, although restoration of progeny yields was not as robust as those seen in
primary cultures. Overall, the data are consistent with our findings that TmeA is
important for chlamydial development and that this phenotype is independent of
TmeB.
DISCUSSION
An obligate intracellular existence presents obvious barriers to direct genetic ma-
nipulation of bacteria. As with Coxiella, Anaplasma, and Ehrlichia spp., the addition of a
FIG 4 Direct evidence of gfp-bla excision. (A) McCoy cells infected with equal IFUs of WT, L2 tmeA, or L2Rif tmeA-lx C. trachomatis were harvested at 24 hpi, and
DNA was extracted for qPCR. Relative copy numbers for tmeA, tmeB, gfp, and cre were assessed by signal normalized to chlamydial 16S rRNA. ND, none detected.
(B) Excision of the reporter cassette confirmed by PCR by amplifying the tmeA locus with primers in the surrounding upstream and downstream regions.
Products are shown resolved in a 1.0% agarose gel. (C) The sequenced tmeAB locus from L2Rif tmeA-lx indicating the remaining loxP scar sequence (underlined).
Flanking DNA appears in blue, while start codons are in green and the tmeA stop is highlighted in red. The noncanonical start codon for TmeB is also depicted.
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biphasic developmental cycle has further complicated progress in Chlamydia spp. (31).
The ability to transform Chlamydia spp. with a stably maintained shuttle vector,
however, has ushered in the ability to inactivate targeted chromosomal genes via
insertion with group II introns or complete gene deletion using FRAEM (11). Both of
FIG 5 Removal of the reporter cassette relieves polar effects on tmeB. (A) The presence of transcripts
downstream of tmeA was determined by reverse transcriptase (RT) quantitative PCR. Total RNA was isolated
from at 24 hpi from McCoy cells infected at an MOI of 1 with WT, L2 tmeA, L2 tmeB, or L2Rif tmeA-lx. Transcripts
for tmeA, tmeB, and ct696 were detected by qRT-PCR, and signals are presented after normalization to ropD.
ND, none detected. (B) Equal quantities of whole-culture material from 24-h cultures infected with equal IFUs
of WT, L2 tmeA, L2Rif tmeA-lx, or L2Rif tmeA-lx ptmeA were probed in immunoblots for TmeA and TmeB. Hsp60
was used as a loading control, and proteins were visualized by chemiluminescence.
FIG 6 L2Rif tmeA-lx manifests a developmental defect in tissue culture. (A) HeLa cultures were infected in triplicate
with equal numbers of Chlamydia spp. (A) or IFUs (B) using L2Rif (WT)  pCompAII or L2Rif tmeA-lx expressing
pCompAII (vector) or ptmeA to achieve an approximate MOI of 0.1. Cultures were methanol fixed and stained for
chlamydiae (left) or processed for enumeration of progeny EBs (right) at 24 hpi. All inclusions were enumerated by
fluorescence staining of chlamydiae in fixed samples, and data for direct and progeny counts are represented as
mean  standard deviation of triplicate samples. A Student t test with Welch’s correction was used to address
significance (*, P  0.02; **, P  0.005).
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these processes require integration of a selectable marker and/or a fluorescence
reporter to recover desired strains due to (i) the numerical confines imposed by the
requirement for cell culture and (ii) low-frequency events. These engineered elements
have the potential to disrupt the possessivity of RNA polymerase and/or translating
ribosomes, thereby impacting de novo synthesis of downstream genes. This is an
important issue given the propensity of bacteria to organize genes into polycistronic
operons (20). While promoter and operon structures have not been well characterized
in Chlamydia spp. (32), transcriptome studies clearly indicate the presence of polycis-
tronic messages. Deep sequencing of the C. trachomatis L2b transcriptome was not of
sufficient depth to identify all transcription start sites (33), yet at least 246 polycistronic
transcripts were detected using a similar approach with the closely related Chlamydia
pneumoniae (34). Therefore, overcoming the possibility of polar effects inherent in the
application of current gene inactivation technologies in Chlamydia spp. is needed.
C. trachomatis tmeA and tmeB represent invasion-related T3SEs that are cotrans-
cribed as a bicistronic operon (25). TmeB levels were significantly reduced when tmeA
was replaced with a gfp-bla cassette via FRAEM (15), raising the possibility of cassette-
dependent polar inactivation. In this study, we have devised an approach that sequen-
tially couples FRAEM-mediated gene deletion with Cre-lox-mediated excision of the
resulting selection cassettes. This approach was applied successfully to generate a
markerless deletion of tmeA that did not negatively impact tmeB expression. Although
the Cre-lox system has been used in Coxiella spp. in a two-step gene deletion strategy,
mutagenesis was accomplished with the benefit of an axenic medium, and the result-
ing deletion strains retained a drug resistance cassette (29). Our work represents the
first application of Cre-lox technology for markerless gene deletion in an obligate
intracellular bacterium during host cell infection.
Cre recombinase mediates the resolution of bacteriophage P1 dimers through
recognition and binding to 34-bp direct repeats termed loxP sites (35). The Cre-lox
system has been adapted to successfully engineer a wide diversity of genomes, and this
includes the excision of selection markers from bacteria (36). For marker removal, Cre
must be present/active subsequent to insertion of the floxed selection cassette and
then eliminated from the genome after successful excision. One strategy developed for
Mycoplasma spp. relied on conditional expression of Cre using a tet-inducible promoter
(37). In this instance, Cre was encoded within the selection cassette such that it was lost
concomitantly with the excision event. Importantly, the loxP scar sequence that remains
after marker excision has not been observed to exert polar effects on downstream
genes (29, 38). Our strategy relies on the expression of Cre in Chlamydia spp. using the
conditionally replicating plasmid pSUmC (30). Cre is constitutively expressed from
pSU-CRE via a blaM promoter, and the plasmid is maintained via selection with Spec
and aTC to induce the expression of pgp6. mCherry is also expressed as a fluorescence
marker. Given the labor-intensive requirements for genetically manipulating chlamyd-
iae, our first step was to ensure that the pSU-CRE-encoded recombinase was active in
E. coli and adequately expressed in WT C. trachomatis without interfering with devel-
opment.
Generation of a markerless deletion mutant began with a Chlamydia strain where
tmeA had been replaced with a gfp-bla cassette flanked by loxP sites. pSU-CRE was then
mobilized into this strain. We are not certain why the strain could not be transformed
with pSU-CRE using the conventional CaCl2 method, but we suspect general low
transformation efficiency in Chlamydia to be the culprit. During the course of our
broader work, we have found that lateral gene transfer (LGT) can be efficiently
leveraged to mobilize engineered plasmids among chlamydial strains. The exchange of
genomic DNA via LGT occurs at a frequency of 103 to 104 (39), yet we find that
plasmid can be transferred 10- to 100-fold more efficiently (not shown). A spontaneous
Rif-resistant strain, L2Rif tmeA-lx-gfp-bla, was generated to allow selective recovery after
coinfection with L2 pSU-CRE. Experiments in E. coli (Fig. 1) were consistent with
Cre-mediated excision of the marker cassette being highly efficient. This was important
since there was no selective pressure for excision of the cassette in Chlamydia species.
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Although there was also no selection to recover markerless chlamydiae, we leveraged
the fluorescence reporting aspect of our constructs to monitor excision and recover
appropriate strains. Indeed, we could readily visualize a minor population of red-only
inclusions after a single passage of L2Rif tmeA-lx-gfp-bla/pSU-CRE. Consistent with
previous observations (15), selective maintenance of an engineered plasmid in chla-
mydiae results in the eventual loss of endogenous pL2 during this process. Therefore,
we leveraged LGT a second time to restore endogenous pL2 after curing of pSU-CRE.
The final strain, L2Rif tmeA-lx, was used for further study.
Overall, our data were consistent with the marker cassette exerting a polar effect on
tmeB in L2 tmeA that was alleviated by excision of gfp-bla in L2Rif tmeA-lx. Both message
and protein levels for tmeB were decreased relative to the WT in L2 tmeA, raising the
possibility that the presence of gfp-bla interfered with mRNA stability and/or transla-
tion. Chlamydial fitness comparisons were made using strains isogenic for Rif, since
mutations conferring this resistance can impact fitness in some bacteria (40). Vector-
only controls were also used given the contributions of pL2-carried genes in chlamydial
infection (41) and observations that ectopic expression of fluorescent proteins can
impact fitness in some bacteria (42). Similar to L2 tmeA (15), the absence of tmeA in L2Rif
tmeA-lx resulted in a decrease in chlamydial infectivity. These data are therefore
consistent with the proposed role of tmeA in chlamydial invasion. Although successful
complementation indicated that this phenotype was due solely to TmeA, the restora-
tion of TmeB in L2Rif tmeA-lx will greatly facilitate further study of TmeA function.
In aggregate, our data provide proof of concept that Cre-lox-mediated recombina-
tion is an effective technique for manipulation of the chlamydial genome. Due to
limitations imposed by culture and genetic manipulation of Chlamydia spp., this
method is necessarily somewhat laborious. It is perhaps most appropriately reserved for
instances when operon-localized genes are targeted for inactivation. Other applications
are clearly possible in addition to alleviation of polar effects. Alternative antibiotic
resistance genes have been used to sequentially engineer a chlamydial strain harboring
two inactivated genes (43). Given the limited number of effective antibiotics available
for positive selection in Chlamydia spp., the Cre-lox system described herein could be
exploited as a mechanism to generate multigene mutant strains. Group II introns have
been widely used to disrupt chlamydial genes (11), and Cre-lox has been used to excise
group II introns in other bacteria (36). However, the lack of a fluorescence reporter in
group II introns would likely complicate strain recovery for Chlamydia species. We
propose that Cre-lox is therefore most appropriate for use with FRAEM. Based on the
wide variety of manipulations that have been accomplished in other genomes, it also
possible that more generalized engineering of the C. trachomatis chromosome can be
performed using Cre-lox. Inversions, insertions, and gene deletions may become pos-
sible as the chlamydial system becomes more tractable.
MATERIALS AND METHODS
Cell culture and organisms. C. trachomatis serovar L2 (LGV 434) and derivative strains were used in
these studies (Table 1). Chlamydiae were routinely maintained in either HeLa 229 epithelial cell
monolayers (CCL-1.2; ATCC) or McCoy cell monolayers (CRL-1696; ATCC). All cultures were grown in RPMI
1640 medium containing 2 mM L-glutamine (Life Technologies) supplemented with 10% (vol/vol)
heat-inactivated fetal bovine serum (FBS; Sigma) at 37°C in an environment with 5% CO2 and 95%
humidified air. All infections were accomplished using density gradient-purified EBs (44) centrifuged onto
cell monolayers at 20°C for 1 h at 900  g. For transformation and FRAEM protocols, chlamydiae were
cultivated in the presence of 600 ng/ml penicillin G (PenG; Sigma), 500 g/ml spectinomycin (Spec; Alfa
Aesar), and 1 g/ml cycloheximide (Sigma), in addition to 50 ng/ml anhydrotetracycline (aTc) where
appropriate. Rifampin (Rif)-resistant strains were generated as described previously (45) by cultivation for
4 passages in 2.5 ng/ml Rif, followed by 4 passages in 5 ng/ml Rif. Clonal isolates for all final Chlamydia
strains were obtained as described by 2 sequential limiting dilution passages in 384 plates (30).
Chlamydial fitness was assessed by enumeration of infectious progeny or quantitative assessment of
inclusion area as described by McKuen et al. (26). Primary infections were carried out using particle- or
inclusion forming unit (IFU)-normalized chlamydiae, as indicated. Penicillin sensitivity assays were carried
out exactly as described by Mueller et al. (15). Escherichia coli NEB-10 (New England Biolabs) was utilized
for cloning procedures and verification of Cre activity. An E. coli dam dcm deletion mutant (NEB) was used
as a host to generate unmethylated plasmid DNA used to transform Chlamydia species. E. coli strains
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were routinely grown at 37°C in Luria-Bertani broth (Amresco) or LB agar plates supplemented with
50 g/ml carbenicillin (Teknova) or 100 g/ml spectinomycin, as appropriate.
DNA methods. All PCR-based amplifications for cloning were performed using Q5 high-fidelity DNA
polymerase (NEB) from plasmid purified from E. coli using the Monarch plasmid miniprep kit (NEB). All
primers were custom DNA oligonucleotides from Integrated DNA Technologies (see Table S1 in the
supplemental material), and final constructs were confirmed by DNA sequencing of engineered regions.
The allelic exchange plasmid pSU-ΔtmeA-lox-gfp-bla was generated by the addition of loxP sites flanking
the bla-gfp cassette. Flanking loxP sites were added via insertion PCR (iPCR) by amplification of the
previously described pUC18Δctl0063 (15) using the loxP-blagfp-F and loxP-blagfp-R primers. DNA
containing the floxed gfp-bla cassette flanked by chlamydial DNA 3 kb up- and downstream of the
deleted tmeA sequence was amplified with HOMRR@pSUmC-F and HOMRR@pSUmC-R primers. The
amplicon was then used in iPCR with pSUmC to yield pSUmC-tmeA-loxP. pSU-CRE was constructed first
by PCR amplifying the complete CRE coding sequence from pSF-CMV-CRE (Sigma) using primers
CRE@pUC18A-F and CRE@pUC18A-R. The amplicon was used in an iPCR reaction to replace bla in
pUC18A (30) with the CRE-encoding DNA. Cre and upstream aadA were then PCR amplified using
CRE-aadA@pSUmC-F and CRE-aadA@pSUmC-R and mobilized into pSUmC via iPCR. A bla promoter (Pbla)
was inserted upstream of cre via iPCR amplification of pSU-aadA-CRE with primers loxP-blagfp-F and
loxP-blagfp-R. The resulting amplicon was kinased, blunt-end ligated, and transformed into E. coli to yield
pSU-CRE.
Cre activity in E. coli was assessed by cotransformation of E. coli with pUC18 containing a floxed gfp
cassette and pSUmC or pSU-CRE. Transformants were screened by fluorescence and PCR with sense and
antisense screening primers (Table S1). PCR screening of chlamydial loci with specific primer sets (Table
S1) was accomplished by harvesting whole-culture DNA using 0.5 N NaOH-mediated lysis, as described
previously (46). For quantitative PCR, iTaq Universal SYBR green supermix (Bio-Rad) and gene-specific
primers (Table S1) were employed. For assessment of gene expression, the Aurum total RNA minikit
(Bio-Rad) was used to isolate RNA from McCoy cultures infected at a multiplicity of infection (MOI) of 1.
Subsequent generation of cDNA was achieved using the QuantiTect reverse transcription kit (Qiagen),
and cDNAs were amplified with iTaq Universal SYBR green supermix (Bio-Rad) and gene-specific primers
(Table S1).
Genetic manipulation of chlamydiae. Transformation of Chlamydia spp. via CaCl2 and allelic
exchange mutagenesis via FRAEM were accomplished as described previously (30). Briefly, 2 g of
unmethylated pSU-CRE or pSUmC-tmeA-lox-gfp-bla was used to transform WT C. trachomatis L2, and
transformants were selected with Spec or Pen, respectively. Generation of the tmeA-lx mutant was
accomplished by first cultivating pSUmC-tmeA-lox-gfp-bla transformants in the absence of aTc for
multiple passages, followed by clonal isolation of Pen-resistant GFP-expressing chlamydiae. The deletion
of tmeA was confirmed by PCR screening with the surroundctl0063-F and surroundctl0063-R primers
(Table S1) and direct DNA sequencing. The intermediate strain, L2 tmeA-lox-gfp-bla, was cultivated in Rif
as described above, and spontaneous Rif-resistant chlamydiae were isolated. pSU-CRE was mobilized into
these chlamydiae by lateral gene transfer. L2Rif tmeA-lox-gfp-bla chlamydiae were used with WT express-
ing pSU-CRE to coinfect McCoy cells at a 10:1 ratio. Cultures were maintained for two 48-h passages in
the presence of aTc and cycloheximide but in the absence of antibiotic selection. Five serial passages
(48 h each) were then performed in the presence of Rif, Spec, aTc, and cycloheximide. Rif- and
Spec-resistant chlamydiae expressing mCherry but not GFP were isolated by limiting dilution. Strains
were cultivated for five serial passages in Rif and cycloheximide, followed by clonal isolation of
Rif-resistant chlamydiae lacking mCherry. The absence of gfp and bla was confirmed via PCR and
penicillin sensitivity assays, respectively. The absence of tmeA was confirmed as described above via PCR
and DNA sequencing. Endogenous pL2 was restored via lateral gene transfer by coinfection with C.
trachomatis L2 tmeA (15) and L2RRif tmeA-lx. The final L2Rif tmeA-lx strain was isolated by limiting dilution
from cultures exposed to Rif. A spontaneously Rif-resistant WT strain was also isolated and, along with
the tmeA-lx mutant, was transformed with pCompAII (15) using Spec selection for the production of
vector-only controls. Complementation of the tmeA mutation was accomplished by transformation of
tmeA-lx with pTmeA (26).
TABLE 1 C. trachomatis strains
Strain designation Plasmid; relevant genotype; antibiotic resistancea Reference or source
L2 (WT) pL2; tmeA ATCC
L2Rif pL2; tmeA; Rifr This study
L2R pL2; tmeA 47
L2/pSU-CRE pL2; tmeA cre mCherry; Specr This study
L2Rif/pCompAII pL2; tmeA gfp mCherry; Rifr Specr This study
L2 tmeA pL2; tmeA absent, gfp-bla; Penr 15
L2Rif tmeA-lx-gfp-bla pL2; tmeA absent, loxP gfp-bla; Rifr Penr This study
L2RRif tmeA-lx pL2; tmeA absent, loxP; Rifr This study
L2Rif tmeA-lx pL2; tmeA absent, loxP; Rifr This study
L2Rif/tmeA-lx pCompAII pL2; tmeA absent, loxP gfp mCherry; Rifr Specr This study
L2Rif/tmeA-lx pTmeA pL2; tmeA loxP mCherry; Rifr Specr This study
L2 tmeB pL2; tmeA absent, gfp-bla; Penr 15
apL2 and pL2 refer to the presence and absence of the endogenous C. trachomatis plasmid, respectively. The coding sequences for Pgp1 to -8 are present on the
engineered plasmids pCompAII, pSU-CRE, and pTmeA.
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Microscopy. E. coli colonies were imaged at 20 using bright-field or epifluorescence microscopy.
Chlamydial inclusions were routinely visualized via GFP or mCherry fluorescence in live cultures or via
indirect immunofluorescence of methanol-fixed cultures using Hsp60 (Santa Cruz), followed by second-
ary antibody conjugated to Alexa Fluor 594 (Invitrogen). For quantitative studies, whole-well fluores-
cence images were acquired using the Cell Insight CX5 platform (Thermo Scientific) and analyzed using
HSC Studio version 6.6 (Thermo Scientific).
Immunoblotting. Whole-culture material was harvested 24 house postinfection (hpi) monolayers
infected at a multiplicity of infection (MOI) of 1. Proteins were precipitated in 10% (vol/vol) trichloroacetic
acid in phosphate-buffered saline (PBS) and solubilized using 3 Laemmli buffer. Proteins were then
resolved by 12% (vol/vol) SDS-PAGE gels and transferred to Immobilon-P membranes (Millipore). Cre
recombinase (Cell Signaling), TmeA (24), TmeB (25), or Hsp60-specific antibodies were used to probe the
blots. Proteins were visualized by probing with horseradish peroxidase-conjugated secondary antibodies
and chemiluminescence detection using Amersham ECL Plus (GE Healthcare UK Limited).
Statistical analysis. All presented data are representative of a minimum of three experiments. Unless
otherwise noted, quantitative data were generated from experiments containing triplicate biological
samples and duplicate technical replicates. Calculation of standard deviation of the mean and assess-
ment via Student’s t test statistical analyses were performed using Prism 6, version 6.04 (GraphPad
Software, Inc., La Jolla, CA).
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